---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-25-000015"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T20:52:55.656267+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# GoodRx appoints Scott Wagner as director, co-chair; Simon Patterson resigns from board

## Summary
- Scott Wagner appointed Class II director, Chair of Compensation Committee, and Co-Chair of the Board effective Jan 21, 2025.
- Wagner previously served as GoodRx Interim CEO from April 2023 to January 2025.
- Simon Patterson resigned as director, not due to any disagreement with Company or management.
- Vacancy filled by Silver Lake Stockholders exercising board designation rights; Wagner appointed.
- Wagner receives standard non-employee director compensation: initial RSU award of $420,000 and pro-rated annual RSU of $85,699.

## SEC filing metadata
- accession: 0001809519-25-000015
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/0001809519-25-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/gdrx-20250121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-25-000015
- JSON: https://secwatch.observer/filing/0001809519-25-000015.json
- Plain text: https://secwatch.observer/filing/0001809519-25-000015.txt

## Key facts
- Executive change
  Scott Wagner was appointed as Class II Director at GoodRx Holdings, Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On January 21, 2025, the Board of Directors (the “Board”) of GoodRx Holdings, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Scott Wagner as a Class II director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/0001809519-25-000015-index.htm
- Executive change
  Simon Patterson resigned as Director at GoodRx Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 21, 2025, Simon Patterson resigned as a member of the Board and as a member of the Board’s Nominating and Corporate Governance Committee and Innovation Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/0001809519-25-000015-index.htm
- Executive change
  Scott Wagner was appointed as Co-Chair of the Board at GoodRx Holdings, Inc..
  - Action: appointed
  - Role: Co-Chair of the Board
  source text: The Board also appointed Mr. Wagner as the Chair of the Board’s Compensation Committee, and appointed Mr. Wagner as a Co-Chair of the Board, to serve in such role together with the existing Chair (now to be referred to as Co-Chair), Trevor Bezdek.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/0001809519-25-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.